86 filings
Page 2 of 5
8-K
73kh6n wgm7m6fh5
8 Nov 21
Reata Pharmaceuticals, Inc. Announces Third Quarter 2021 Financial Results and Provides an Update on Clinical Development Programs
6:45am
8-K
zld82fuz 3cx
22 Oct 21
Departure of Directors or Certain Officers
6:02am
8-K
plt2gok
20 Aug 21
Entry into a Material Definitive Agreement
4:19pm
8-K
0l3hy1ld
9 Aug 21
Reata pharmaceuticals, inc. announces SECOND quarter 2021 financial RESULTS and provides an update on CLINICAL DEVELOPMENT programs
4:06pm
8-K
i75o728v
23 Jun 21
Departure of Directors or Certain Officers
4:15pm
8-K
685io0l armz8k757x
11 Jun 21
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
wrs4x4s h3wykml
6 May 21
Reata pharmaceuticals, inc. announces First quarter 2021 financial RESULTS and provides an update on CLINICAL DEVELOPMENT programs
6:50am
8-K
ncsre6hpfsl dqjxb
15 Apr 21
REATA Announces THE APPOINTMENTs OF Christy J. Oliger and Shamim Ruff TO ITS BOARD OF DIRECTORS
6:50am
8-K
059dm
1 Mar 21
Reata pharmaceuticals, inc. announces FOURTH quarter AND FULL YEAR 2020 financial RESULTS and provides an update on CLINICAL DEVELOPMENT programs
6:40am
8-K
bbbt ljqinpq
11 Jan 21
Regulation FD Disclosure
6:30am
8-K
jxu hgb4v
3 Dec 20
Entry into a Material Definitive Agreement
4:45pm
8-K
7v0591 0qb
9 Nov 20
Vinny Jindal; Reata Pharmaceuticals Inc.; VP of Strategy
5:30pm
8-K
hff m7xrqytqb2l
9 Nov 20
Reported positive year 2 data from the pivotal CARDINAL study of bardoxolone methyl in patients with chronic kidney disease caused by Alport syndrome
6:51am
8-K
20s1k
27 Aug 20
Departure of Directors or Certain Officers
8:00am
8-K
7iflqa75uxhl4l hqe
10 Aug 20
PRE-NDA (NEW DRUG APPLICATION) MEETING GRANTED for Bardoxolone
6:51am
8-K
6y2z4ae8xd
30 Jul 20
Reata Announces the Appointment of Martin W. Edwards, M.D. to Its Board of Directors
9:16pm
8-K
z6tc4mld8qn0uy8jc
7 Jul 20
Reata Announces promotion and New hires for key leadership roles
6:50am
8-K
sx1c33
24 Jun 20
Reata PHARMACEUTICALS, Inc. CLOSES $350 Million strategic investment from blackstone life sciences
10:23am
8-K
bf4r65 0lt8o
11 Jun 20
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
i4z27761
11 Jun 20
Reata Pharmaceuticals, Inc. and Blackstone Life Sciences Announce $350 Million Strategic Investment
9:26am